Adaptimmune Therapeutics
(NASDAQ:ADAP)
$1.70
-0.01[-0.58%]
At close: Jun 30
$1.70
00
After Hours: 4:39PM EDT
Day High/Low1.63 - 1.76
52 Week High/Low1.26 - 6.86
Open / Close1.71 / 1.7
Float / Outstanding- / 162M
Vol / Avg.331.1K / 561.9K
Mkt Cap275.4M
P/E-
50d Avg. Price1.64
Div / Yield-
Payout Ratio-
EPS-0.3
Total Float142.6M

Adaptimmune Therapeutics (NASDAQ:ADAP), Quotes and News Summary

Adaptimmune Therapeutics (NASDAQ: ADAP)

Day High/Low1.63 - 1.76
52 Week High/Low1.26 - 6.86
Open / Close1.71 / 1.7
Float / Outstanding- / 162M
Vol / Avg.331.1K / 561.9K
Mkt Cap275.4M
P/E-
50d Avg. Price1.64
Div / Yield-
Payout Ratio-
EPS-0.3
Total Float142.6M
Sector: Health Care.Industry: Biotechnology
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A10 T-cell therapy, NON-SMALL CELL LUNG CANCER, AFP SPEAR T-cell, MAGE-A4 SPEAR T-cell therapy and NY-ESO SPEAR T-cell for multiple cancer types.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS-0.220-0.050 0.1700
REV3.290M3.575M285.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Adaptimmune Therapeutics Questions & Answers

Q
How do I buy Adaptimmune Therapeutics (ADAP) stock?
A

You can purchase shares of Adaptimmune Therapeutics (NASDAQ: ADAP) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Adaptimmune Therapeutics's (ADAP) competitors?
Q
What is the target price for Adaptimmune Therapeutics (ADAP) stock?
A

The latest price target for Adaptimmune Therapeutics (NASDAQ: ADAP) was reported by SVB Leerink on Monday, May 9, 2022. The analyst firm set a price target for 3.00 expecting ADAP to rise to within 12 months (a possible 76.47% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Adaptimmune Therapeutics (ADAP)?
A

The stock price for Adaptimmune Therapeutics (NASDAQ: ADAP) is $1.7 last updated June 30, 2022, 8:00 PM UTC.

Q
Does Adaptimmune Therapeutics (ADAP) pay a dividend?
A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q
When is Adaptimmune Therapeutics (NASDAQ:ADAP) reporting earnings?
A

Adaptimmune Therapeutics’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is Adaptimmune Therapeutics (ADAP) going to split?
A

There is no upcoming split for Adaptimmune Therapeutics.

Q
What sector and industry does Adaptimmune Therapeutics (ADAP) operate in?
A

Adaptimmune Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.